Tumour glycolysis: the many faces of HIF - PubMed

Affiliations

• PMID: 18639251
• DOI: 10.1016/j.jtbi.2008.05.025

Free article

Tumour glycolysis: the many faces of HIF

Catherine Kelly et al. J Theor Biol. 2008.

Free article

Abstract

We present a model for tumour metabolism that incorporates both microenvironmental (extracellular) and oncogenic (intracellular) influences. We explore the effects of the interaction between the hypoxic microenvironment and intracellular signalling on the glycolytic response of tumour tissue, finding that the glycolytic state is dependent on a delicately balanced interplay between the cellular hypoxic response, mediated by hypoxia-inducible factor-1alpha (HIF-1alpha), and growth-factor signalling cascades, which are frequently mutated in cancers. Our findings demonstrate the importance of considering both environmental and intracellular regulation when interpreting tumour metabolism for diagnostic or prognostic purposes. To illustrate this, we demonstrate the potential impact of this multi-factorial regulation on the kinetics of radiolabelled glucose analogues, used in positron emission tomography (PET).

Similar articles

• Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.

  Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M. Hamaguchi T, et al. Int J Oncol. 2008 Oct;33(4):725-31. Int J Oncol. 2008. PMID: 18813785

• Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

  Poon E, Harris AL, Ashcroft M. Poon E, et al. Expert Rev Mol Med. 2009 Aug 27;11:e26. doi: 10.1017/S1462399409001173. Expert Rev Mol Med. 2009. PMID: 19709449 Review.

• Harnessing the hypoxia-inducible factor in cancer and ischemic disease.

  Brahimi-Horn MC, Pouysségur J. Brahimi-Horn MC, et al. Biochem Pharmacol. 2007 Feb 1;73(3):450-7. doi: 10.1016/j.bcp.2006.10.013. Epub 2006 Oct 20. Biochem Pharmacol. 2007. PMID: 17101119 Review.

• Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.

  Ishikawa T, Nakashiro K, Klosek SK, Goda H, Hara S, Uchida D, Hamakawa H. Ishikawa T, et al. Oncol Rep. 2009 Mar;21(3):707-12. Oncol Rep. 2009. PMID: 19212630

• Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid.

  Hata Y, Sassa Y, Kita T, Miura M, Kano K, Kawahara S, Arita R, Nakao S, Shih JL, Ishibashi T. Hata Y, et al. Br J Ophthalmol. 2008 Nov;92(11):1540-4. doi: 10.1136/bjo.2008.141002. Br J Ophthalmol. 2008. PMID: 18952656

Cited by

• Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.

  Nakamura M, Kitagawa Y, Yamazaki Y, Hata H, Kotsuji M, Fujibayashi Y, Okazawa H, Yonekura Y, Sano K. Nakamura M, et al. Odontology. 2012 Jan;100(1):87-94. doi: 10.1007/s10266-011-0024-3. Epub 2011 May 13. Odontology. 2012. PMID: 21567121

• HIF1α-dependent glycolysis promotes macrophage functional activities in protecting against bacterial and fungal infection.

  Li C, Wang Y, Li Y, Yu Q, Jin X, Wang X, Jia A, Hu Y, Han L, Wang J, Yang H, Yan D, Bi Y, Liu G. Li C, et al. Sci Rep. 2018 Feb 26;8(1):3603. doi: 10.1038/s41598-018-22039-9. Sci Rep. 2018. PMID: 29483608 Free PMC article.

• Comprehensive profiling of zebrafish hepatic proximal promoter CpG island methylation and its modification during chemical carcinogenesis.

  Mirbahai L, Williams TD, Zhan H, Gong Z, Chipman JK. Mirbahai L, et al. BMC Genomics. 2011 Jan 4;12:3. doi: 10.1186/1471-2164-12-3. BMC Genomics. 2011. PMID: 21205313 Free PMC article.

• Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.

  Moldogazieva NT, Mokhosoev IM, Terentiev AA. Moldogazieva NT, et al. Cancers (Basel). 2020 Apr 2;12(4):862. doi: 10.3390/cancers12040862. Cancers (Basel). 2020. PMID: 32252351 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • CORE
  • Elsevier Science